Champel Capital

Champel Capital is a venture capital firm founded in 2017 and located in Jerusalem, Israel. The firm focuses on investing in emerging start-ups across various sectors, including deep healthcare technology, food tech, agritech, software, mobility, artificial intelligence, the internet of things, insurtech, and fintech. Champel Capital aims to support innovative companies that are poised for growth within the Israeli market.

Omer Bohbot

Agritech and Foodtech Analyst

13 past transactions

Indoor Robotics

Series A in 2022
Indoor Robotics is the creator of Tando, one of a kind flying robot. Leveraging independent AI based navigation and patented unobtrusive ceiling docking Tile™, Tando provides real-time coverage with AI based predictive analysis that eliminates false alarms. Its fully automated data collection and analysis ensures consistent quality and fewer safety and security risks. Our combined solution of robotics paired with AI powered capabilities enable the most cost-effective and efficient solution for intelligent indoor monitoring and inspection. Partnering with global leaders in the security and smart building arenas and led by top experts with decades of experience in robotics and smart building automation, Indoor Robotics are shaping the future of intelligent Indoor monitoring and inspection.

Innoviz Technologies

Series B in 2020
Innoviz is a manufacturer of solid-state LiDAR sensors and perception software that enable the mass-production of autonomous vehicles. InnovizPro is a solid-state LiDAR that offers outstanding performance and value for automotive and other applications. InnovizOne is a cutting-edge, automotive-grade LiDAR sensor that provides superior 3D sensing for Level 3-Level 5 autonomous driving. The company is backed by top-tier strategic partners and investors, including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital (SINO-BLR Industrial Investment Fund, L.P.), 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company, and others.

IntraPosition

Venture Round in 2018
IntraPosition streamlines operations in healthcare using best-in-class positioning technology. Our real-time location systems (RTLS) utilize proprietary real-time location technology based on UWB communication.

IntraPosition

Seed Round in 2018
IntraPosition streamlines operations in healthcare using best-in-class positioning technology. Our real-time location systems (RTLS) utilize proprietary real-time location technology based on UWB communication.

Body Vision Medical

Series B in 2018
Body Vision Medical eliminates CT-to-body divergence and provides visual confirmation of tool-in-lesion prior to biopsy, while intraoperative CT imaging and enhanced fluoroscopy provide unparalleled control over diagnostic output. They can be a dedicated intraoperative 3D imaging solution for tool-in-lesion confirmation or a standalone navigational bronchoscopy platform.

AiLert

Pre Seed Round in 2018
AiLert’s SAMSON is a weapon detector for already installed security cameras. It empowers individuals, schools and businesses to make communities safer.

Vascular Graft Solutions

Series B in 2018
VGS develops innovative solutions to improve the outcome of bypass surgery and patients’ quality of life. VEST, the company’s leading product, is designed for use in Coronary Artery Bypass Grafting, to mitigate disease progression in venous bypass grafts and improve their long term performance.
Vectorious Medical Technologies developed the V-LAP, the worlds first in-heart microcomputer which enables optimal treatment for heart failure patients, increasing their quality of life and life expectancy. The V-LAP sensory implant is the first digital, wireless, battery-less device that is able to communicate from deep within the body. It monitors the heart’s left atrium pressure (LAP) which has been proven to be the earliest, most accurate and effective predictor for heart failure deterioration. Vectorious is actively conducting clinical studies in Europe (Italy, Germany, UK and Israel) for the purpose of obtaining a CE mark. It is expected to launch a clinical study in the US in 2020.

Lemonade

Series B in 2018
Lemonade operates as a full-stack insurance company powered by AI and behavioral economics and driven by social good. It is a licensed insurance carrier, offering homeowners and renters insurance. Lemonade replaces brokers and bureaucracy with bots and machine learning, delivering zero paperwork and instant everything. The company uses artificial intelligence and behavioral economics to set rates for the homes and renters it insures. Lemonade was founded in Tel Aviv, Israel, in 2015 and is headquartered in New York, NY, United States.

Laminate Medical

Series B in 2017
Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the first year. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.

Ametrine Technologies

Seed Round in 2017
Ametrine Technologies provides battle proven, advanced camouflage technology to address the growing threat of multispectral sensors. The company's products are breathable and durable and has been validated by the Naval Research Laboratory. The company's technology delivers thermal and visual camouflage by causing targets to blend with the background, rather than attempting to block the radiation emitted by the target. It incorporates the latest lightweight, outdoor textiles to provide users with the ultimate cloaking technology. The systems allow users to operate on the modern battlefield unseen and with complete mobility.

SmarTap

Series A in 2017
SmarTap is all about making showers smarter, safer, and greener. They have developed our patented shower system from the ground up, staying focused on our main goals: creating a smart, cost effective, and reliable next generation shower. They are an experienced group of highly motivated professionals, who are never afraid to take on any challenge. When they started our adventure they intentionally set high goals for ourselves, and today SmarTap’s digital shower system has exceeded all of them!

Neurolief

Series A in 2017
Neurolief is a neuromodulation company dedicated to bringing relief to patients suffering from mental health and neurological disorders. The company consists of highly experienced professionals with a proven track record in neuroscience, neuromodulation technology, and the neurotech industry. Neurolief has developed a disruptive platform technology, the world's first and only non-invasive, multi-channel brain neuromodulation system designed to concurrently neuromodulate major neural pathways in the head and thereby affect brain regions involved in the control and modulation of mood and pain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.